Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically
Riches, Lucy C, Trinidad, Antonio G, Hughes, Gareth, Jones, Gemma N, Hughes, Adina M, Thomason, Andrew G, Gavine, Paul, Cui, Andy, Ling, Stephanie, Stott, Jonathan, Clark, Roger, Peel, Samantha, Gill, Pendeep, Goodwin, Louise M, Smith, Aaron, Pike, Kurt G, Barlaam, Bernard, Pass, Martin, O'Connor, Mark J, Smith, Graeme, Cadogan, Elaine B
Published in Molecular cancer therapeutics (01.01.2020)
Published in Molecular cancer therapeutics (01.01.2020)
Get full text
Journal Article
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA -Mutated Breast and Gynecologic Cancers
Banerji, Udai, Dean, Emma J, Pérez-Fidalgo, J Alejandro, Batist, Gerald, Bedard, Philippe L, You, Benoit, Westin, Shannon N, Kabos, Peter, Garrett, Michelle D, Tall, Mathew, Ambrose, Helen, Barrett, J Carl, Carr, T Hedley, Cheung, S Y Amy, Corcoran, Claire, Cullberg, Marie, Davies, Barry R, de Bruin, Elza C, Elvin, Paul, Foxley, Andrew, Lawrence, Peter, Lindemann, Justin P O, Maudsley, Rhiannon, Pass, Martin, Rowlands, Vicky, Rugman, Paul, Schiavon, Gaia, Yates, James, Schellens, Jan H M
Published in Clinical cancer research (01.05.2018)
Published in Clinical cancer research (01.05.2018)
Get full text
Journal Article
The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro‑2H‑pyran-4-yl)-1,3-dihydro‑2H‑imidazo[4,5‑c]quinolin-2-one)
Pike, Kurt G, Barlaam, Bernard, Cadogan, Elaine, Campbell, Andrew, Chen, Yingxue, Colclough, Nicola, Davies, Nichola L, de-Almeida, Camila, Degorce, Sebastien L, Didelot, Myriam, Dishington, Allan, Ducray, Richard, Durant, Stephen T, Hassall, Lorraine A, Holmes, Jane, Hughes, Gareth D, MacFaul, Philip A, Mulholland, Keith R, McGuire, Thomas M, Ouvry, Gilles, Pass, Martin, Robb, Graeme, Stratton, Natalie, Wang, Zhenhua, Wilson, Joanne, Zhai, Baochang, Zhao, Kang, Al-Huniti, Nidal
Published in Journal of medicinal chemistry (10.05.2018)
Published in Journal of medicinal chemistry (10.05.2018)
Get full text
Journal Article
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules
Guichard, Sylvie M, Curwen, Jon, Bihani, Teeru, D'Cruz, Celina M, Yates, James W T, Grondine, Michael, Howard, Zoe, Davies, Barry R, Bigley, Graham, Klinowska, Teresa, Pike, Kurt G, Pass, Martin, Chresta, Christine M, Polanska, Urszula M, McEwen, Robert, Delpuech, Oona, Green, Stephen, Cosulich, Sabina C
Published in Molecular cancer therapeutics (01.11.2015)
Published in Molecular cancer therapeutics (01.11.2015)
Get full text
Journal Article
Induction of heart valve lesions by small-molecule ALK5 inhibitors
Anderton, Mark J, Mellor, Howard R, Bell, Alex, Sadler, Claire, Pass, Martin, Powell, Steve, Steele, Samantha J, Roberts, Ruth R A, Heier, Annabelle
Published in Toxicologic pathology (01.10.2011)
Published in Toxicologic pathology (01.10.2011)
Get more information
Journal Article
Discovery of Checkpoint Kinase Inhibitor (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas
Oza, Vibha, Ashwell, Susan, Almeida, Lynsie, Brassil, Patrick, Breed, Jason, Deng, Chun, Gero, Thomas, Grondine, Michael, Horn, Candice, Ioannidis, Stephanos, Liu, Dongfang, Lyne, Paul, Newcombe, Nicholas, Pass, Martin, Read, Jon, Ready, Shannon, Rowsell, Siân, Su, Mei, Toader, Dorin, Vasbinder, Melissa, Yu, Dingwei, Yu, Yan, Xue, Yafeng, Zabludoff, Sonya, Janetka, James
Published in Journal of medicinal chemistry (14.06.2012)
Published in Journal of medicinal chemistry (14.06.2012)
Get full text
Journal Article
Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT
Kettle, Jason G, Brown, Simon, Crafter, Claire, Davies, Barry R, Dudley, Phillippa, Fairley, Gary, Faulder, Paul, Fillery, Shaun, Greenwood, Hannah, Hawkins, Janet, James, Michael, Johnson, Keith, Lane, Clare D, Pass, Martin, Pink, Jennifer H, Plant, Helen, Cosulich, Sabina C
Published in Journal of medicinal chemistry (09.02.2012)
Published in Journal of medicinal chemistry (09.02.2012)
Get full text
Journal Article
Abstract 3343: The pre-clinical in vitro and in vivo activity of AZD6738: A potent and selective inhibitor of ATR kinase
Guichard, Sylvie M., Brown, Elaine, Odedra, Rajesh, Hughes, Adina, Heathcote, Dan, Barnes, Jen, Lau, Alan, Powell, Steve, Jones, Clifford D., Nissink, Willem, Foote, Kevin M., Jewsbury, Philip J., Pass, Martin
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Discovery of a novel class of triazolones as Checkpoint Kinase inhibitors—Hit to lead exploration
Oza, Vibha, Ashwell, Susan, Brassil, Patrick, Breed, Jason, Deng, Chun, Ezhuthachan, Jay, Haye, Heather, Horn, Candice, Janetka, James, Lyne, Paul, Newcombe, Nicholas, Otterbien, Ludo, Pass, Martin, Read, Jon, Roswell, Sian, Su, Mei, Toader, Dorin, Yu, Dingwei, Yu, Yan, Valentine, Anna, Webborn, Peter, White, Ann, Zabludoff, Sonya, Zheng, Xiaolan
Published in Bioorganic & medicinal chemistry letters (01.09.2010)
Published in Bioorganic & medicinal chemistry letters (01.09.2010)
Get full text
Journal Article
Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitors
Janetka, James W., Almeida, Lynsie, Ashwell, Susan, Brassil, Patrick J., Daly, Kevin, Deng, Chun, Gero, Thomas, Glynn, Roberta E., Horn, Candice L., Ioannidis, Stephanos, Lyne, Paul, Newcombe, Nicholas J., Oza, Vibha B., Pass, Martin, Springer, Stephanie K., Su, Mei, Toader, Dorin, Vasbinder, Melissa M., Yu, Dingwei, Yu, Yan, Zabludoff, Sonya D.
Published in Bioorganic & medicinal chemistry (15.07.2008)
Published in Bioorganic & medicinal chemistry (15.07.2008)
Get full text
Journal Article
AKT Inhibition in Solid Tumors With AKT1 Mutations
Hyman, David M, Smyth, Lillian M, Donoghue, Mark T A, Westin, Shannon N, Bedard, Philippe L, Dean, Emma J, Bando, Hideaki, El-Khoueiry, Anthony B, Pérez-Fidalgo, José A, Mita, Alain, Schellens, Jan H M, Chang, Matthew T, Reichel, Jonathan B, Bouvier, Nancy, Selcuklu, S Duygu, Soumerai, Tara E, Torrisi, Jean, Erinjeri, Joseph P, Ambrose, Helen, Barrett, J Carl, Dougherty, Brian, Foxley, Andrew, Lindemann, Justin P O, McEwen, Robert, Pass, Martin, Schiavon, Gaia, Berger, Michael F, Chandarlapaty, Sarat, Solit, David B, Banerji, Udai, Baselga, José, Taylor, Barry S
Published in Journal of clinical oncology (10.07.2017)
Published in Journal of clinical oncology (10.07.2017)
Get full text
Journal Article
Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background
Davies, Barry R, Greenwood, Hannah, Dudley, Phillippa, Crafter, Claire, Yu, De-Hua, Zhang, Jingchuan, Li, Jing, Gao, Beirong, Ji, Qunsheng, Maynard, Juliana, Ricketts, Sally-Ann, Cross, Darren, Cosulich, Sabina, Chresta, Christine C, Page, Ken, Yates, James, Lane, Clare, Watson, Rebecca, Luke, Richard, Ogilvie, Donald, Pass, Martin
Published in Molecular cancer therapeutics (01.04.2012)
Published in Molecular cancer therapeutics (01.04.2012)
Get full text
Journal Article
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
CHRESTA, Christine M, DAVIES, Barry R, JAMES, Dominic, HOWARD, Zoe, DUDLEY, Phillippa, HUGHES, Gareth, SMITH, Lisa, MAGUIRE, Sharon, HUMMERSONE, Marc, MALAGU, Karine, MENEAR, Keith, JENKINS, Richard, HICKSON, Ian, JACOBSEN, Matt, SMITH, Graeme C. M, GUICHARD, Sylvie, PASS, Martin, HARDING, Tom, COSULICH, Sabina, CRITCHLOW, Susan E, VINCENT, John P, ELLSTON, Rebecca, JONES, Darren, SINI, Patrizia
Published in Cancer research (Chicago, Ill.) (2010)
Published in Cancer research (Chicago, Ill.) (2010)
Get full text
Journal Article
Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study
Jucaite, Aurelija, Stenkrona, Per, Cselényi, Zsolt, De Vita, Serena, Buil-Bruna, Nuria, Varnäs, Katarina, Savage, Alicia, Varrone, Andrea, Johnström, Peter, Schou, Magnus, Davison, Chris, Sykes, Andy, Pilla Reddy, Venkatesh, Hoch, Matthias, Vazquez-Romero, Ana, Moein, Mohammad Mahdi, Halldin, Christer, Merchant, Melinda S, Pass, Martin, Farde, Lars
Published in Neuro-oncology (Charlottesville, Va.) (12.04.2021)
Published in Neuro-oncology (Charlottesville, Va.) (12.04.2021)
Get full text
Journal Article
Abstract 4909: Adaptive oncology phase 1 study of first-in-class inhibitor of ataxia telangiectasia mutated protein kinase (ATM), in combination with olaparib
Chen, Yingxue, Pass, Martin, Bruna, Nuria Bui, Stephens, Christine, Pierce, Andrew, Hanekom, Wouter, Gabra, Hani, Tomkinson, Helen, Al-Huniti, Nidal
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER + Invasive Breast Cancer (STAKT)
Robertson, John F R, Coleman, Robert E, Cheung, Kwok-Leung, Evans, Abigail, Holcombe, Chris, Skene, Anthony, Rea, Daniel, Ahmed, Samreen, Jahan, Ali, Horgan, Kieran, Rauchhaus, Petra, Littleford, Roberta, Cheung, S Y Amy, Cullberg, Marie, de Bruin, Elza C, Koulai, Loumpiana, Lindemann, Justin P O, Pass, Martin, Rugman, Paul, Schiavon, Gaia, Deb, Rahul, Finlay, Pauline, Foxley, Andrew, Gee, Julia M W
Published in Clinical cancer research (01.04.2020)
Published in Clinical cancer research (01.04.2020)
Get full text
Journal Article
The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one)
Pike, Kurt G, Barlaam, Bernard, Cadogan, Elaine, Campbell, Andrew, Chen, Yingxue, Colclough, Nicola, Davies, Nichola L, de-Almeida, Camila, Degorce, Sebastien L, Didelot, Myriam, Dishington, Allan, Ducray, Richard, Durant, Stephen T, Hassall, Lorraine A, Holmes, Jane, Hughes, Gareth D, MacFaul, Philip A, Mulholland, Keith R, McGuire, Thomas M, Ouvry, Gilles, Pass, Martin, Robb, Graeme, Stratton, Natalie, Wang, Zhenhua, Wilson, Joanne, Zhai, Baochang, Zhao, Kang, Al-Huniti, Nidal
Published in Journal of medicinal chemistry (10.05.2018)
Published in Journal of medicinal chemistry (10.05.2018)
Get full text
Journal Article
Abstract 4868: A preclinical PK/PD model based on a mouse glioblastoma survival model for AZD1390, a novel, brain-penetrant ATM kinase inhibitor, to predict the inhibition of DNA damage response induced by radiation and the human efficacious dose
Reddy, Venkatesh Pilla, Sykes, Andy, Colclough, Nicola, Durant, Stephen T., O'Connor, Lenka Oplustil, Hoch, Matthias, Bruna, Nuria Buil, Vita, Serena De, Merchant, Melinda, Pass, Martin
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
Durant, Stephen T, Zheng, Li, Wang, Yingchun, Chen, Kan, Zhang, Lingli, Zhang, Tianwei, Yang, Zhenfan, Riches, Lucy, Trinidad, Antonio G, Fok, Jacqueline H L, Hunt, Tom, Pike, Kurt G, Wilson, Joanne, Smith, Aaron, Colclough, Nicola, Reddy, Venkatesh Pilla, Sykes, Andrew, Janefeldt, Annika, Johnström, Peter, Varnäs, Katarina, Takano, Akihiro, Ling, Stephanie, Orme, Jonathan, Stott, Jonathan, Roberts, Caroline, Barrett, Ian, Jones, Gemma, Roudier, Martine, Pierce, Andrew, Allen, Jasmine, Kahn, Jenna, Sule, Amrita, Karlin, Jeremy, Cronin, Anna, Chapman, Melissa, Valerie, Kristoffer, Illingworth, Ruth, Pass, Martin
Published in Science advances (01.06.2018)
Published in Science advances (01.06.2018)
Get full text
Journal Article
Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
Robertson, John F.R., Coleman, Robert E., Cheung, Kwok-Leung, Evans, Abigail, Holcombe, Chris, Skene, Anthony, Rea, Daniel, Ahmed, Samreen, Jahan, Ali, Horgan, Kieran, Rauchhaus, Petra, Littleford, Roberta, Amy Cheung, S.Y., Cullberg, Marie, de Bruin, Elza C., Koulai, Loumpiana, Lindemann, Justin P.O., Pass, Martin, Rugman, Paul, Schiavon, Gaia, Deb, Rahul, Finlay, Pauline, Foxley, Andrew, Gee, Julia M.W.
Published in Clinical cancer research (15.12.2022)
Published in Clinical cancer research (15.12.2022)
Get full text
Journal Article